FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
Featured Photo Galleries
Military parade celebrates Army’s 250th
Cheers and chants rang out Saturday from a crowd of thousands as soldiers manned modern and historic tanks and aircraft for the Army’s 250th anniversary celebration in the District.
Ovi scores goal 890, Caps lose to Sabres 8-5
Alexander Ovechkin scored goal number 890, but the Washington Capitals fell short, losing to the visiting Buffalo Sabres Sunday afternoon 8-5 at Capital One Arena in Washington D.C., March 30, 2025 (Photos for the Washington Times.)
Hegseth joins veterans, generals to mark 80th anniversary of battle of Iwo Jima
A handful of retired Marines – all in the late 90s or over 100 — joined Defense Secretary Pete Hegseth and Japan’s Prime Minister Takeru Ishida on Saturday to mark the anniversary of one of the bloodiest battles of World War II in the Pacific that ended 80 years ago this week.
